Analgesics and Anti-inflammatory Drugs Practice Questions

Q: FK-506 is used in which of the following conditions?

Organ transplant. **Explanation:** **FK-506**, also known as **Tacrolimus**, is a potent immunosuppressant belonging to the **calcineurin inhibitor** class. **Why Option A is correct:** Tacrolimus works by binding to an intracellular protein called **FK-binding protein (FKBP)**. This complex inhibits **calcineurin**, a phosphatase enzyme required for the activation of the nuclear factor of activated T-cells (NFAT). By preventing NFAT activation, it inhibits the transcription of **Interleukin-2 (IL-2)** and other cytokines, thereby suppressing T-cell proliferation. This mechanism is vital in preventing **allograft rejection** in organ transplant recipients (e.g., kidney, liver, or heart). **Why other options are incorrect:** * **B. Bronchial asthma:** Asthma is managed with bronchodilators and corticosteroids. While Tacrolimus suppresses immune responses, it is not a standard treatment for asthma. * **C. Diabetic diarrhea:** This is usually a result of autonomic neuropathy and is managed with glycemic control or symptomatic treatments like loperamide; Tacrolimus has no role here. * **D. Chemotherapeutic agent:** Tacrolimus is an immunosuppressant, not a cytotoxic drug used to kill cancer cells. **High-Yield Clinical Pearls for NEET-PG:** * **Potency:** Tacrolimus is roughly **10–100 times more potent** than Cyclosporine. * **Side Effects:** Unlike Cyclosporine, Tacrolimus does **not** cause hirsutism or gum hyperplasia. However, it has a higher incidence of **post-transplant diabetes mellitus (PTDM)** and neurotoxicity (tremors). * **Topical Use:** Tacrolimus ointment is highly effective for **Atopic Dermatitis**. * **Metabolism:** It is metabolized by **CYP3A4**; therefore, grapefruit juice can increase its toxicity.

Q: Cyclosporine acts by decreasing the production of which of the following interleukins?

IL-2. ### Explanation **Mechanism of Action (Why B is correct):** Cyclosporine is a potent immunosuppressant that acts as a **Calcineurin Inhibitor**. Under normal physiological conditions, when a T-cell is activated, intracellular calcium increases and binds to calmodulin. This complex activates **calcineurin**, a phosphatase that dephosphorylates **NFAT** (Nuclear Factor of Activated T-cells). Dephosphorylated NFAT enters the nucleus to promote the transcription of various cytokines, most importantly **Interleukin-2 (IL-2)**. Cyclosporine binds to an intracellular protein called **Cyclophilin**. The resulting Cyclosporine-Cyclophilin complex inhibits calcineurin, preventing the dephosphorylation of NFAT. This leads to a profound **decrease in IL-2 production**, which is the primary driver for T-cell proliferation and differentiation. **Analysis of Incorrect Options:** * **A (IL-1):** Primarily produced by macrophages and monocytes. While cyclosporine has some indirect effects on macrophages, its primary target is the T-cell signaling pathway. * **C (IL-6) & D (IL-8):** These are pro-inflammatory cytokines involved in the acute phase response and neutrophil chemotaxis, respectively. They are not the primary targets of calcineurin inhibitors. **High-Yield NEET-PG Pearls:** * **Drug of Choice:** Cyclosporine is used for GVHD prophylaxis and organ transplant rejection. * **Metabolism:** Metabolized by **CYP3A4**; avoid grapefruit juice (inhibitor). * **Side Effects (High Yield):** "The 4 H's" — **H**irsutism, **H**yperplasia of gums (gingival), **H**ypertension, and **H**yperlipidemia. * **Nephrotoxicity:** This is the most common and dose-limiting side effect. * **Comparison:** Unlike Tacrolimus (which binds to FKBP-12), Cyclosporine binds to Cyclophilin, but both inhibit Calcineurin.

Q: Which of the following is NOT a TNF–α antagonist used in rheumatoid arthritis?

Ifosfamide. ### Explanation The correct answer is **Ifosfamide**. **1. Why Ifosfamide is the correct answer:** Ifosfamide is an **alkylating agent** belonging to the nitrogen mustard group. It is a cytotoxic chemotherapy drug used primarily in the treatment of various cancers (e.g., testicular cancer, sarcomas, lymphomas) [2]. It works by cross-linking DNA strands, thereby inhibiting DNA replication. It has no role as a TNF-α antagonist and is not used in the management of rheumatoid arthritis (RA). **2. Analysis of Incorrect Options (TNF-α Antagonists):** TNF-α (Tumor Necrosis Factor-alpha) is a key pro-inflammatory cytokine involved in the pathogenesis of RA. The following are Biological Disease-Modifying Antirheumatic Drugs (bDMARDs) that target it: * **Infliximab:** A chimeric monoclonal antibody that binds to both soluble and transmembrane TNF-α. * **Etanercept:** A soluble **fusion protein** (TNF receptor linked to the Fc fraction of IgG1) that acts as a "decoy receptor" to soak up circulating TNF-α [1]. * **Adalimumab:** A fully human recombinant monoclonal antibody against TNF-α. **3. High-Yield Clinical Pearls for NEET-PG:** * **Ifosfamide Toxicity:** A high-yield side effect is **Hemorrhagic Cystitis**, caused by the metabolite **Acrolein**. This is prevented by aggressive hydration and the administration of **MESNA** (2-Mercaptoethane sulfonate Na). * **TNF-α Inhibitor Screening:** Before starting any TNF-α antagonist, patients **must** be screened for **Latent Tuberculosis** (using TST or IGRA) because these drugs can cause reactivation of TB. * **Other TNF-α Inhibitors:** Certolizumab (pegylated) and Golimumab [1]. * **Memory Aid:** Remember the "mabs" (monoclonal antibodies) and the "cept" (receptor) for TNF blockers. Ifosafamide sounds like Cyclophosphamide, both of which are anticancer alkylators.

Q: A reasonable explanation for the therapeutic effects of ibuprofen or naproxen in primary dysmenorrhea is that these drugs are associated with which of the following?

inhibition of prostaglandin synthesis (PGE2 and PGF2a). **Explanation:** **1. Why Option A is Correct:** Primary dysmenorrhea is primarily caused by the excessive release of prostaglandins (**PGE2 and PGF2α**) from the endometrium during menstruation. These prostaglandins cause potent uterine contractions, leading to myometrial ischemia and pain. Ibuprofen and Naproxen are non-selective **Non-Steroidal Anti-inflammatory Drugs (NSAIDs)** that inhibit the enzyme **Cyclooxygenase (COX)**. By blocking COX, they reduce the synthesis of these specific prostaglandins, thereby decreasing uterine hypercontractility and providing symptomatic relief. **2. Why Other Options are Incorrect:** * **Option B:** While some COX-2 inhibitors exist (e.g., Celecoxib), Ibuprofen and Naproxen are **non-selective** inhibitors of both COX-1 and COX-2. COX-1 inhibition is actually significant in the endometrium. * **Option C:** NSAIDs do not inhibit the Lipoxygenase (LOX) pathway; therefore, they do not reduce **leukotriene** synthesis. In fact, by blocking the COX pathway, arachidonic acid may be shunted toward the LOX pathway (the basis for NSAID-exacerbated respiratory disease). * **Option D:** **Phospholipase A2** is inhibited by **Corticosteroids** (via annexin-1/lipocortin), not by NSAIDs. PLA2 is an upstream enzyme that releases arachidonic acid from membrane phospholipids. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** NSAIDs are the first-line medical treatment for primary dysmenorrhea. * **Timing:** For maximum efficacy, NSAIDs should be started at the onset of menses or 1–2 days prior. * **Specific Prostaglandin:** **PGF2α** is the most potent stimulator of uterine smooth muscle and is the primary target in dysmenorrhea management. * **Side Effect Profile:** Non-selective NSAIDs can cause gastric irritation due to the inhibition of protective COX-1 in the gastric mucosa.

Q: Which of the following is NOT a TNF-neutralizing agent?

Rituximab. **Explanation:** The question asks to identify the drug that does not neutralize Tumor Necrosis Factor (TNF). **Correct Answer: D. Rituximab** Rituximab is a **chimeric monoclonal antibody directed against the CD20 antigen** found on the surface of B-lymphocytes. It works by depleting B-cells rather than neutralizing TNF-α. It is primarily used in Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia (CLL), and severe Rheumatoid Arthritis (RA) refractory to TNF inhibitors. **Why the other options are incorrect (TNF-neutralizing agents):** * **A. Infliximab:** A chimeric monoclonal antibody that binds directly to soluble and transmembrane TNF-α. * **B. Etanercept:** A soluble recombinant **fusion protein** (TNF receptor linked to Fc fraction of IgG1) that acts as a "decoy receptor" to soak up circulating TNF. * **C. Adalimumab:** A fully human monoclonal antibody against TNF-α, which has lower immunogenicity compared to Infliximab. **High-Yield Clinical Pearls for NEET-PG:** 1. **TNF Inhibitors Mnemonic:** "Every Indian Always Gets Certolizumab" (**E**tanercept, **I**nfliximab, **A**dalimumab, **G**olimumab, **C**ertolizumab). 2. **Pre-requisite:** Before starting any TNF inhibitor, patients must be screened for **Latent Tuberculosis** (using TST or IGRA) because TNF is essential for granuloma maintenance; inhibiting it can cause TB reactivation. 3. **Certolizumab pegol** is unique because it is "pegylated" and lacks an Fc portion, reducing placental transfer (safer in pregnancy). 4. **Rituximab Side Effect:** Infusion-related reactions and Progressive Multifocal Leukoencephalopathy (PML) due to JC virus reactivation.

Q: Which of the following agents is not used for the treatment of erectile dysfunction?

Phenylephrine. **Explanation:** The treatment of erectile dysfunction (ED) focuses on increasing blood flow to the *corpora cavernosa* through vasodilation. **Phenylephrine** is a selective **$\alpha_1$-adrenergic agonist** that causes potent vasoconstriction. In the context of male reproductive health, it is used to treat **priapism** (a prolonged, painful erection) by constricting the cavernous arteries and promoting detumescence. Therefore, it is the "odd one out" as it reverses an erection rather than treating ED. **Analysis of Other Options:** * **Vardenafil (Option B):** A selective **PDE-5 inhibitor**. It prevents the breakdown of cGMP, leading to smooth muscle relaxation and increased blood flow. It is a first-line oral treatment for ED. * **Alprostadil (Option D):** This is a synthetic **Prostaglandin E1 (PGE1)** analogue. It increases cAMP levels, causing direct vasodilation. It is administered via intracavernosal injection or intraurethral pellets. * **PGE2 (Option A):** While PGE1 (Alprostadil) is the standard, PGE2 (Dinoprostone) also possesses vasodilatory properties. Historically, it has been used in combination therapies (like "Trimix" or "Quadmix") for ED, though it is more commonly associated with labor induction. **NEET-PG High-Yield Pearls:** 1. **Drug of Choice (DOC) for Priapism:** Intracavernosal Phenylephrine. 2. **PDE-5 Inhibitors Contraindication:** Never co-administer with **Nitrates**, as it can lead to severe, life-threatening hypotension. 3. **Alprostadil Side Effect:** The most common side effect of the injectable form is penile pain and risk of priapism. 4. **Sildenafil (Viagra):** Also used in Pulmonary Arterial Hypertension (PAH).

Q: Which of the following actions is ascribed to delta type of opioid receptors?

Supraspinal analgesia. Opioid receptors are G-protein coupled receptors (GPCRs) categorized into three main types: **Mu (μ), Kappa (κ), and Delta (δ)**. Understanding their distinct physiological effects is high-yield for NEET-PG. ### **Explanation of the Correct Option** **A. Supraspinal analgesia:** Delta (δ) receptors are primarily located in the pontine nuclei, amygdala, and deep layers of the cerebral cortex. Their activation leads to both **supraspinal and spinal analgesia**. While Mu receptors are the primary mediators of analgesia, Delta receptors play a significant modulatory role, particularly in chronic pain states. ### **Explanation of Incorrect Options** * **B. Respiratory depression:** This is a classic side effect primarily mediated by **Mu (μ₂)** receptors. Activation of Mu receptors in the brainstem respiratory centers decreases responsiveness to CO₂. * **C. Euphoria:** This is predominantly associated with **Mu (μ)** receptor activation. In contrast, Kappa (κ) receptor activation often leads to the opposite effect—dysphoria and hallucinations. * **D. Reduced intestinal motility:** Constipation is mediated by **Mu (μ₂)** receptors located in the myenteric plexus of the gastrointestinal tract. ### **High-Yield Clinical Pearls for NEET-PG** * **Mu (μ):** Responsible for most clinical effects—Supraspinal analgesia (μ₁), Respiratory depression, Constipation, Euphoria, and Physical dependence (μ₂). * **Kappa (κ):** Responsible for Spinal analgesia, Miosis (pin-point pupil), and Dysphoria. * **Delta (δ):** Responsible for Supraspinal/Spinal analgesia and potentially modulating emotional responses (Anxiolysis). * **Pure Antagonist:** **Naloxone** and **Naltrexone** antagonize all three receptor types (Mu, Kappa, and Delta). * **Endogenous Ligands:** Enkephalins have the highest affinity for **Delta** receptors, Endorphins for **Mu**, and Dynorphins for **Kappa**.

Q: Which of the following NSAIDs has been approved for use in children?

Ibuprofen. **Explanation:** **Correct Answer: B. Ibuprofen** **Medical Concept:** Pediatric pharmacotherapy requires drugs with a high safety profile and well-established dosing guidelines. **Ibuprofen** is one of the most commonly used and safest NSAIDs in children. It is FDA-approved for use in infants as young as **6 months** for its analgesic, anti-inflammatory, and antipyretic properties. It works by reversibly inhibiting COX-1 and COX-2 enzymes. Along with Paracetamol, it is a first-line agent for managing pediatric fever and pain. **Analysis of Incorrect Options:** * **A. Indomethacin:** While used in neonates specifically for the medical closure of **Patent Ductus Arteriosus (PDA)**, it is generally avoided as a routine analgesic/antipyretic in children due to its high incidence of systemic side effects (GI bleed, renal toxicity). * **C. Ketorolac:** This is a potent NSAID primarily used for short-term management of severe post-operative pain. It is generally not recommended for routine use in children under 16 years (or strictly limited to inpatient settings) due to the high risk of gastrointestinal bleeding and renal impairment. * **D. Piroxicam:** This oxicam derivative has a very long half-life (~50 hours), making it difficult to manage in pediatric populations where metabolic rates vary. It is associated with a higher risk of serious skin reactions (Stevens-Johnson Syndrome). **High-Yield NEET-PG Pearls:** * **Aspirin Warning:** Never use Aspirin in children with viral infections (Flu, Chickenpox) due to the risk of **Reye’s Syndrome** (fulminant hepatic failure and encephalopathy). * **Drug of Choice for PDA:** Intravenous **Indomethacin** or **Ibuprofen** (Ibuprofen is often preferred now due to less renal vasoconstriction). * **Safe Age:** Ibuprofen is typically started after 6 months; Paracetamol (Acetaminophen) can be used from birth.

Q: Which analgesic can itself cause headache as a side effect?

Indomethacin. **Explanation:** **Indomethacin** is a potent, non-selective COX inhibitor known for its high incidence of adverse effects, occurring in approximately 35–50% of patients. The most characteristic side effect is a **frontal headache**, which occurs in up to 25% of chronic users. 1. **Why Indomethacin is correct:** The mechanism behind the "Indomethacin headache" is thought to be related to its chemical structure (an indole derivative) which is similar to serotonin. It can cause cerebral vasoconstriction or direct CNS toxicity. This headache is often accompanied by dizziness, vertigo, and confusion, a cluster of symptoms sometimes referred to as "Indomethacin-induced CNS toxicity." 2. **Why other options are incorrect:** * **Mefenamic acid:** Primarily used for dysmenorrhea; its most notable side effects are diarrhea and hemolytic anemia, not headaches. * **Piroxicam:** An oxicam derivative with a long half-life. Its main toxicity is a high risk of GI ulceration and skin reactions (Stevens-Johnson Syndrome). * **Aspirin:** While aspirin overdose causes **Salicylism** (tinnitus, dizziness, hyperventilation), it is actually a primary treatment for headaches rather than a common cause of them. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** Indomethacin is the DOC for **Ankylosing Spondylitis**, **Bartter Syndrome**, and **Acute Gout**. * **PDA:** It is used to medically close a Patent Ductus Arteriosus in neonates. * **Contraindication:** Due to its high CNS side effect profile, it should be avoided in patients with epilepsy, psychosis, or Parkinsonism. * **Memory Aid:** Remember "Indo-**meth**-acin" affects the "**head**" (CNS).

Question 1

FK-506 is used in which of the following conditions?

Accepted Answer

Organ transplant

Answer

Bronchial asthma

Answer

Diabetic diarrhea

Answer

Chemotherapeutic agent

Question 2

Cyclosporine acts by decreasing the production of which of the following interleukins?

Accepted Answer

IL-2

Answer

IL-1

Answer

IL-6

Answer

IL-8

Question 3

Which of the following is NOT a TNF–α antagonist used in rheumatoid arthritis?

Accepted Answer

Ifosfamide

Answer

Infliximab

Answer

Etanercept

Answer

Adalimumab

Question 4

A reasonable explanation for the therapeutic effects of ibuprofen or naproxen in primary dysmenorrhea is that these drugs are associated with which of the following?

Accepted Answer

inhibition of prostaglandin synthesis (PGE2 and PGF2a)

Answer

selective inhibition of COX-2

Answer

inhibition of leukotriene synthesis (LTB4)

Answer

inhibition of phospholipase A2 (PLA2)

Question 5

Which of the following is NOT a TNF-neutralizing agent?

Accepted Answer

Rituximab

Answer

Infliximab

Answer

Etanercept

Answer

Adalimumab

Question 6

Which of the following agents is not used for the treatment of erectile dysfunction?

Accepted Answer

Phenylephrine

Answer

PGE2

Answer

Vardenafil

Answer

Alprostadil

Question 7

Which of the following actions is ascribed to delta type of opioid receptors?

Accepted Answer

Supraspinal analgesia

Answer

Respiratory depression

Answer

Euphoria

Answer

Reduced intestinal motility

Question 8

Which of the following NSAIDs has been approved for use in children?

Accepted Answer

Ibuprofen

Answer

Indomethacin

Answer

Ketorolac

Answer

Piroxicam

Question 9

Which analgesic can itself cause headache as a side effect?

Accepted Answer

Indomethacin

Answer

Mefenamic acid

Answer

Piroxicam

Answer

Aspirin

Question 10

All of the following are opioid agonist-antagonist compounds EXCEPT?

Accepted Answer

Papaverine

Answer

Buprenorphine

Answer

Nalbuphine

Answer

Pentazocine

Analgesics and Anti-inflammatory Drugs — MCQs

Analgesics and Anti-inflammatory Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?